
|Articles|June 18, 2007
Latebreakers: Revision made of Actos label
A request from the FDA has led to a revision of the prescribing information for pioglitazone (Actos, Takeda Pharmaceuticals).
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
FDA-Approved Sunscreen Filter Bemotrizinol Debuts in New US Products
2
Updated Guideline Refines Approach to Migraine Prevention in Adults
3
Women, Men With Type 2 Diabetes Face Different Paths to Complications
4
The Drug Price Paradox: PBMs, Pharmacies, and the Path to Affordability
5































